Inside Perspectives on Cancer Immunotherapy: An Interview with TCR2 Therapeutics CEO Garry Menzel On May 19, 2017 / OPUS Clients in the News Read more →
Gut Instinct: Leveraging the Microbiome and Human Immune System to Dramatically Transform Medicine On May 17, 2017 / OPUS Clients in the News Read more →
Improving the Odds in Cancer With First-Time Immunotherapies On May 11, 2017 / OPUS Clients in the News Read more →
Inside Perspectives on Immunotherapy: An Interview with Advaxis CEO Daniel O’Connor On May 9, 2017 / OPUS Clients in the News Read more →
